The Office of Inspector General reported $4.3 billion in investigative receivables, $814.1 million in audit and evaluation receivables and $447.6 million in potential cost savings during a six-month period.
By yourNEWS Media Newsroom
WASHINGTON — The federal agency responsible for investigating fraud, waste and abuse across U.S. healthcare programs identified $5.56 billion in expected recoveries and potential savings during the six months ending in March, according to its latest report to Congress.
The Department of Health and Human Services’ Office of Inspector General reported the financial results for the period from October 2025 through March 2026.
The total consisted of $4.3 billion in investigative receivables, $814.1 million in audit and evaluation receivables and $447.6 million in potential cost savings.
The amounts do not represent money already collected by the government.
According to the report’s glossary, investigative receivables are amounts that individuals or entities were ordered or agreed to repay to federal or state governments following OIG investigations.
Those investigations may result in criminal proceedings, civil or administrative settlements, civil judgments or other administrative actions.
Audit and evaluation receivables are amounts that an organization examined by the inspector general has agreed should not be charged to the government.
Potential cost savings refer to funds that could be “put to better use” if HHS implements recommendations issued by the watchdog.
The OIG said its work produced $12.70 in expected recoveries and savings for every dollar spent on its operations.
Enforcement actions during the reporting period led to 1,212 individuals being excluded from participation in federal healthcare programs.
Inspector General Thomas March Bell said the agency remained focused on pursuing people and organizations that exploit programs intended to serve low-income families, people with disabilities and other vulnerable populations.
“OIG is determined to hold bad actors accountable,” Bell said.
“Notable actions include convictions of individuals running sham hospices, identification of improper payments and vulnerabilities in emerging risk areas such as Medicaid payments for autism services, and uncovering gaps in foster care systems that contributed to failures to track and find missing children.”
The report highlighted enforcement activity throughout the healthcare system, including criminal fraud cases, improper-payment reviews and examinations of weaknesses in federal and state programs.
One case involved the chief executive of a healthcare software company who was sentenced to 15 years in prison last year and ordered to pay $452 million in restitution.
The executive was convicted of conspiracy for orchestrating a telemedicine and durable medical equipment fraud operation valued at approximately $1 billion.
The OIG also examined emerging areas of potential financial risk, including Medicaid payments for autism-related services.
Its work identified improper payments and program vulnerabilities that could expose federal healthcare funds to fraud, waste or mismanagement.
The watchdog additionally reported finding deficiencies in foster care systems that contributed to failures to properly track and locate missing children.
Many OIG investigations originate with information submitted through the agency’s public hotline.
During the six-month reporting period, investigators evaluated more than 40,800 tips involving allegations of fraud, waste, abuse or mismanagement in federal healthcare programs.
The report did not show an increase in the number of enforcement actions compared with the corresponding period under the previous administration.
Combined criminal and civil actions declined to 604 during the latest reporting period, down from 833 in the prior comparable period.
Despite the decrease in total actions, the OIG reported billions of dollars in expected recoveries and potential savings and more than 1,200 exclusions from federal healthcare programs.
The agency said its enforcement, audit and evaluation work remains focused on protecting federal funds, identifying vulnerabilities and preventing people convicted of misconduct from continuing to participate in government healthcare programs.
Original article
Comments